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INTRODUCTION NEWS ARTICLES Equine Influenza outbreaks in UK -a practical approach to prevention
The total number of laboratory confirmed equine influenza (EI) outbreaks at time of publication of this report is now over 215 distinct foci. This second quarter of 2019 saw a steady increase in the number of confirmed outbreaks, with June seeing the highest number of outbreak reports so far this year. It should be remembered that this is most likely to be an underestimation of the true extent of EI in the UK at the present time, with an unknown number of outbreaks probably going undiagnosed for a variety of reasons.
In understanding the reasons for the now evident sustained week-on-week increase in numbers of confirmations of EI since the end of April, we probably can't overlook the effect of increased movement and mixing of horses during the late spring and summer months as a contributing factor. Furthermore, where this involves attendance by animals that have not been vaccinated at events (here referring broadly to horse gatherings of any kind) which do not mandate EI vaccination as an entry requirement and/or police such a policy, then this is a recipe for effective and potentially escalating transmission.
We would use it only as an example as it is not unique but following travel and mixing of a large population of predominantly unvaccinated horses at Appleby Horse Fair in early June, there was a subsequent increase in the number of confirmed flu outbreaks, where links to this event were clearly cited by vets attending sick horses. Outbreaks with links to Appleby spanned all corners of the country, from Somerset, to Sussex and mid-Glamorgan to Tyne and Wear (see page 6 of this report for a map of confirmed outbreaks during Q1 and Q2).
We urge the profession to continue to ensure owners and event organisers are made aware of the messages and detail on the following pages.
HORSES ATTENDING EVENTS
 Ensure all horses attending events are vaccinated. We would strongly advise events only accept horses that have had a booster within the last 6 months (rather than annual) and also enforcing the minimum 5 day rule post vaccination (interval between last vaccine dose and competition entry to have some benefit from that vaccination).
 EI vaccination status should ideally be confirmed prior to arrival of all competitors.
 Ensure there has been no recent history of infectious disease on competitors' home yards, before they leave for the event. This could be in the form of a signed health declaration stating this and also ask owners to take and note down the horses temperature prior to travel. Encourage owners to be responsible and aware that even if their own horse appears ok, there is the potential for subclinical influenza infection from other infected horses on their yard.
Advise owners on biosecurity at the competition and when they get back to their home premises too. This should include:  Take own equipment, including water buckets and water.  Avoid communal troughs and do not share any equipment.  Prevent direct and indirect contact between horses.  Don't allow horses to graze communal areas.  Avoid horse-to-horse contact and other people touching your horse.  Disinfect equipment, vehicles and boots after the event.  Continue to closely monitor horses for a few weeks after the event, including daily temperature monitoring.  Encourage owners to contact their vet at the earliest opportunity if they have concerns with their horse.
NEW ARRIVING HORSES AND GOOD-PRACTICE AT VETTINGS
The veterinary profession are integral in promoting preventive measures to mitigate infectious disease transmission among all veterinary species, including equines. It is evident from our surveillance data that a very high proportion of the confirmed EI outbreaks this year are as a result of recent new arrivals bringing infection on to premises, either acquired from the exporting premises or during travel. Worryingly some of these had been noted to be coughing at pre-purchase examination prior to their arrival at the receiving premises and some had received a first EI vaccination in the few days preceding the EI diagnosis, with owners perhaps not being aware that a single first vaccination would not impart immunity.
Some sensible basic steps are as follows  Isolate animals immediately that develop clinical signs, including raised temperatures, which ideally should be being taken twice daily and systematically recorded so that changes in patterns are immediately obvious.
 Quarantine all new arrivals, even when a horse appears outwardly healthy, ideally for 21 days, so that if they develop clinical signs they will not pose an infectious risk to the resident population.
 Discuss the practicalities of isolation/quarantine facilities with your clients, offering advice on how to make an isolation area, even for yards where it appears impossible:  Use a separate stable (no shared airspace) or paddock with dedicated water source or set aside a stable block or double fence an area of field -isolate away from walkways, tape around the entrance, use clear signage, have handwashing and foot dip facilities available.  Ensure the area is a minimum of 10 metres from other stables or paddock borders; ideally the longer the separation the better, especially for EI, however it does have to be practical and made use of.  Make sure that there is no shared airspace with other horses  Use separate labelled equipment, a separate muck heap and separate handlers  Ensure new arrivals are vaccinated against EI, remembering that horses will only have protection from vaccination from two weeks after the second vaccine dose of the primary course. Make sure owners are aware of this and recommend that owners only accept new arrivals at least two weeks after the second vaccination.
 Discuss further laboratory infectious disease testing of quarantined new arrivals with owners, for example using serology to confirm a horse is not likely to be a strangles carrier. There may be merit in taking a nasopharyngeal swab from a horse within 48 hours prior to it leaving the exporting premises and testing it for EI by qPCR.
LEADING BY EXAMPLE
 Wherever possible, vets should only visit suspect infectious disease cases at the end of the day, as the last call. Encourage receptionists to seek veterinary opinion if they have suspicions an appointment may be infectious. Check you have the required equipment in the car including; coveralls, shoe covers, disinfectant e.g. Virkon powder sachets and the all-important nasopharyngeal swabs and transport media.
 Obviously all vets have ended up at a call with a horse unexpectedly having overt clinical signs of suspected infectious disease. It is worth having a protocol in place for this eventuality, with appropriate equipment in your car to decontaminate afterwards.
 Optimise your biosecurity between routine calls, alcohol hand gel and wiping down stethoscopes as a bare minimum. Perhaps the steering wheel might benefit from a little clean too once in a while!?
 Discuss with colleagues about biosecurity at the practice and what protocols individuals adopt, identify any loopholes and share and adopt best practices between you. Questions include -Do those handling sick in-patients also have their owner horses at home? -Do staff change clothes between work and seeing their own horses?
Further information regarding outbreak locations, monthly and weekly totals can be found on page 6. Also see www.equiflunet.org.uk for further information on EI and real time reports of outbreaks.
Equine Viral Arteritis -an update on the outbreaks reported in the UK during 2019
In April 2019, the UK's Chief Veterinary Officer confirmed three cases of Equine Viral Arteritis (EVA) in non -Thoroughbred stallions on a premises in Dorset. In May, a fourth case was also confirmed in a nonThoroughbred stallion at a premises in Devon and this case had epidemiological links to the outbreak in Dorset.
In July 2019, a case of EVA was confirmed on a premises in Shropshire. This outbreak appears to be unrelated to the cases in Devon and Dorset. The affected horse was an unvaccinated non-Thoroughbred stallion with no clinical signs of disease. The horse had not been used for breeding activities in the UK and was undergoing pre-breeding screening by PCR on semen. Under the EVA Order 1995, the case had been reported to the Regional Veterinary Lead at Defra and investigations were ongoing. Due to the known carrier status of persistent shedding in the semen of stallions, the owner of the stallion intended to castrate it and will complete serological testing of all contacts for disease clearance, in accordance with the requirements of the Horserace Betting Levy Board Code of Practice for EVA.
Prior to the confirmation of three outbreaks this year; the last reported case in the UK was in 2012. Being endemic in many parts of mainland Europe, the majority of cases being subclinical and the potential for a chronic carrier status in stallions; post-import testing, heightened vigilance and pre-breeding screening are more important than ever for prevention of this disease.
DEFRA, BEVA and AHT are advising vigilance and encouraging people to re-familiarise themselves, where necessary, with the possible presentations of the disease and routes of transmission.

Whilst acute infection may present with clinical respiratory signs or abortion, signs may also be inapparent
The virus can be transmitted directly or indirectly via all bodily fluids
The infection has the potential for subclinical respiratory transmission as well as the more commonly recognised venereal route of spread.
Pre-breeding testing prior to AI or natural mating of all mares and stallions (including teasers) is vital and especially in breeds or on yards where it has not previously been common practice. It should also be remembered that importing breeding animals from countries that are endemic for EVA, including mainland Europe, carries a tangible risk of introducing EVA. Breeding mares and stallions should be tested for EVA within 28 days before travel and testing should be repeated at least 14 days after arrival and prior to commencing natural mating or AI. Equine Herpes Virus-1 (EHV-1) Neurological Disease On 9 April 2019, AHT confirmed a case of EHV-1 neurological disease on a premises in London. The affected horse was an unvaccinated teenaged non-Thoroughbred that presented with ataxia and a serous nasal discharge. The positive diagnosis was confirmed by PCR on a nasopharyngeal swab. There were around 30 unvaccinated in contacts and there was a history of nasal discharge and coughing amongst the group during the last eight weeks. The neurological case received medical treatment and made a full recovery.
As per HBLB guidelines and with advice from AHT's epidemiology team, all horses on the premises underwent further diagnostic testing to establish the extent of the spread of infection among the group and to assist in establishment of preventative biosecurity measures to prevent further exposure and spread. Serological testing (complement fixation test) demonstrated that the majority of animals on the premises had evidence of exposure, as was expected when history and clinical signs were evaluated alongside titres. However, a subset had low titres and no history of clinical signs. This group were treated as a separate entity, with strict biosecurity instigated. Voluntary movement restrictions were lifted once there had been no evidence of circulating virus among the group for two weeks, confirmed through establishing that there were stable serological titres between blood samples taken two weeks apart and close clinical monitoring, including temperature monitoring.
See Q4 2018 Defra report page 10 for further information on confirming a diagnosis of EHV-1 in a case demonstrating neurological signs.
Equine Viral Arteritis (EVA)
On 4 
GRASS SICKNESS SURVEILLANCE report for the second quarter 2019
Equine Grass Sickness (EGS) surveillance scheme was established in spring 2008 to facilitate the investigation of changes in geographical distribution and incidence of the disease in Great Britain. Data gathered by this scheme is collated in a strictly confidential database.
Reported EGS cases during Q2 2019 were as follows:
Having up to date reports from across the country will help provide an accurate representation of numbers of EGS cases nationwide and is vital to help continue epidemiological research into the disease.
Reporting cases of EGS can be done by either the attending veterinary surgeon or the owner, by following www.grasssickness.org.uk/research/reporting-grass-sickness-cases or by phoning 01638 555 399. 
APHA Salmonella results
Sixty-eight samples were submitted in the second quarter of 2019 to the Animal and Plant Health Agency (APHA) and 66 (97%) of these were positive for Salmonella. A large proportion of the reports have arisen from horses at rescue centres (50%) and stud farms (27%). From the incidents involving isolates typed by the APHA, the serovars/phagetypes reported were: S. Oslo (18 samples), S. Typhimurium (17 samples), monophasic S. Typhimurium (13 samples; 12 DT193), S. Bovismorbificans (7 samples), S. Newport (5 samples), S. Enteritidis (2 samples ), single isolations of S. Dublin and S. Kingston and two untypable Salmonellas. Various different phagetypes of S. Typhimurium were isolated including DT1, DT8, DT41, DT193, U188, U302. Wild and game birds are likely to be associated with DT1 and DT41, whereas pigs are likely to be the origin of U302, monophasic S. Typhimiurium DT193 and S. Bovismorbificans. S. Typhimiurium DT8 is associated with farmed ducks and S. Enteritidis can be found in humans and poultry. S. Newport is usually associated with badgers and S. Oslo appears to be circulating within the equine population. For more information from APHA about Salmonella in Great Britain, please see the 2017 Salmonella in livestock surveillance report https://www.gov.uk/government/publications/salmonella-in-livestock-production-in-great-britain-2017
Toxicosis and Parasitology
A summary of diagnostic toxicosis and parasitology testing undertaken by contributing laboratories is presented in Tables 3 and 4 respectively. Results for toxicosis are based on histopathologically confirmed evidence of disease only (where applicable). Ten reports were of single cases on ten separate premises, seven had an unknown vaccination status, one case was vaccinated and one was confirmed as unvaccinated. One outbreak involved several unvaccinated horses. For all outbreaks, positive diagnoses were confirmed by PCR on fetal tissues. Two cases had a co-infection with leptospirosis and one had a coinfection with leptospirosis and S zooepidemicus.
One outbreak involved two unvaccinated mares aborting amongst a group of 22 mares. One outbreak involved six mares aborting in a large group of late-term pregnant mares, followed by severe neurological diseases in five of the mares, resulting in euthanasia.
Two reports involved single cases of abortion and one involved two vaccinated mares aborting. For all, the positive diagnoses were confirmed by PCR on fetal tissue.
Positive diagnoses were confirmed by PCR on fetal and placental tissues.
Three separate outbreaks were reported and all were vaccinated Thoroughbreds.
Respiratory Diseases
A single case of abortion in an unvaccinated mare, exposed to horses that had been to a recent equine event.
Coital Exanthema (EHV-3)
A single case was confirmed in a non-Thoroughbred that had signs of pyrexia and clinical signs suggestive of the disease. The positive diagnosis was confirmed by PCR on a swab
Equine Herpes Virus-4 (EHV-4) Abortion
The affected case was unvaccinated and the positive diagnosis was confirmed by PCR on fetal tissue.
Leptospiral Abortion
Positive diagnosis was confirmed by PCR on placenta.
Contagious Equine Metritis (CEM)
Outbreaks of CEM were confirmed on 22 Icelandic horses on several different premises. Cases included three mares and 19 stallions
Streptococcus zooepidemicus Abortion
The mare aborted at nine months gestation. The positive diagnosis was confirmed by PCR on fetal tissues. 
Equine Herpes Virus-1/-4 (EHV-1/-4) Respiratory Infection
International: EHV remains endemic in most countries and outbreaks are thought to be under-reported.
Outbreak reports for each country rely on confirmation of disease through laboratory testing and therefore numbers of reports are highly likely to not correlate with the true disease frequency in that country for this reason.
Equine Herpes Virus-1 (EHV-1) Respiratory Infection
All outbreaks involved single cases. Reported clinical signs included; coughing, nasal discharge, limb oedema, lymphadenopathy and pyrexia
One outbreak involved one case and one involved five horses with clinical signs of coughing and nasal discharge.
Outbreaks were confirmed on five separate premises.
The single reported outbreak had three horses affected.
Equine Herpes Virus-4 (EHV-4) Respiratory Infection
Clinical signs included coughing, nasal discharge pyrexia. Where reported, eight reports were of single cases being affected, two outbreaks involved two horses in each and one outbreak reported eight horses with clinical signs. For all, positive diagnoses were made by PCR on a nasopharyngeal swab.
Outbreaks of EHV-4 affecting 11 horses on several premises were reported during second quarter 2019. Clinical signs included pyrexia and respiratory disease. Positive diagnoses were confirmed by PCR on nasal swabs.
Three horses presented with clinical signs of pyrexia and mild purulent nasal discharge. One horse was positive for EHV-4 and three were positive for Streptococcus zooepidemicus.
Equine Influenza (EI) Europe
There have been 97 laboratory confirmed outbreaks of EI during Q2 and verbal reports of many unconfirmed outbreaks. Risk factors for outbreaks include mixing of horses at equine gatherings, new arrivals on premises and horses being unvaccinated. The combined Q1 and Q2 total is 160 outbreaks. 
Rest of World
Almost 4000 cases have been reported and two deaths.
Two of the outbreaks were reported to involve vaccinated horses.
Rhodococcus equi
A case was confirmed in a one-month-old foal and clinical signs included depression, pyrexia, cough, abscess and dyspnea. A pulmonary abscess was found on ultrasound examination and neutrophilia was also reported. There was one in contact with clinical signs.
On 7 June 2019, the Irish Equine Centre confirmed that recent laboratory submissions suggested that conditions were conducive to the development of R. equi infection in foals both in Ireland and in England.
Strangles
International: Strangles remains endemic in most countries. 
Eastern Equine Encephalitis
All outbreaks were reported in Florida. When reported, three horses were vaccinated, five were unvaccinated. Six cases required euthanasia and one was recovering with supportive care.
Equine Encephalosis Virus
Sporadic cases of EEV were reported from six of South Africa's nine Provinces
Equine Herpes Virus-1 (EHV-1) Neurological Disease
A single case was reported in an older aged horse that required euthanasia.
Positive diagnoses were confirmed by PCR on nasopharyngeal swabs and/or EDTA-blood.
Nine cases were reported to be recovering and one required euthanased. Three outbreaks involved vaccinated horses , four involved horses that had an incomplete vaccination history or were unvaccinated and one outbreak involved horses with mixed vaccination statuses. Ages of affected animals ranged from seven-24 years-old, with an average age of 16-years-old. Outbreaks were reported in Arizona, Idaho, Nevada, Pennsylvania, Texas, Washington and Wyoming. Six outbreaks involved horses that had attended recent equine events.
West Nile Virus (WNV)
One case was confirmed in the North West Province.
Both outbreaks involved single cases on premises in Iowa. One case had not history of vaccination and one case was lapse vaccinated. 
African Horse Sickness (AHS) Two reports were made to the OIE. The first involved 148 cases, 8 deaths and the second involved 124 cases and 36 deaths. Positive diagnoses were confirmed by serology (ELISA).
Two reports were made to the OIE. The first involved 159 cases, 114 deaths and the second involved 217 cases and 206 deaths. Positive diagnoses were confirmed by serology (ELISA).
One outbreak involved one case with 35 in-contacts , one involved two cases with 56 in contacts, one involved one case that died, with two in contacts and one involved one case with seven in contacts.
AHS is endemic in South Africa except in the AHS controlled area in the Western Cape Province. AHS cases continued to occur at above average incidence in the endemic area of South Africa, with cases occurring in eight of the nine provinces. There were no cases of AHS in the Western Cape Province, either in the infected part of the province or in the AHS controlled area.
Atypical Myopathy
Europe: On 3 June 2019, the University of Liege updated that there had been 109 cases of atypical myopathy confirmed in Europe since 1 April 2019. This included 45 cases in France.
Equine Infectious Anaemia (EIA)
One case had clinical signs, the rest were subclinically infected.
A subclinical case was confirmed in an imported horse. All in contacts tested negative.
The confirmed case had clinical signs of disease.
The majority of reports involved a single case being confirmed positive.
There were 18 confirmed subclinical cases on one premises and all were euthanased.
Hendra
A case was confirmed in an unvaccinated 25-year-old mare near Scone. This is much further south in New South Wales compared to locations of previous cases. The case was euthanased.
Piroplasmosis
Piroplasmosis is regarded as endemic in South Africa and sporadic cases were reported throughout the country.
Rotavirus
Outbreaks were reported to involve between one to three cases. Clinical signs included diarrhoea and positive diagnoses were confirmed by PCR. When reported, cases were aged two-months old, two, three, 10 and 22-years olds.
Two foals on one premises were reportedly affected. fig. 1 ), before extending to the conjunctiva ( fig. 2 ) and then the remainder of the head and neck. The distal limbs and ventral abdomen are only rarely affected. Dyspnoea, cyanosis, abdominal pain and heart failure can also occur. The cardiac form is less clinically severe and more protracted than the pulmonary form, with fatality in >50% of cases.
Vesicular Stomatitis
A look at: African Horse Sickness (AHS)
Virus classification: Genus: orbivirus. Double-stranded RNA. 9 antigenically distinct serotypes
Transmission: Vector-borne disease (midges). No direct spread between animals.
Clinical signs: Four clinical syndromes; pulmonary, cardiac, mixed and subclinical. Signs include; pyrexia (up to 41°C), redness of conjunctivae, swelling of the face, neck and shoulders, frothing and discharge from nostrils, slow and heavy breathing, coughing. High mortality.
Diagnosis: ELISA/viral neutralization/PCR/viral isolation on tissues. PCR/viral isolation on blood.
Serology on a blood sample (ELISA/complement fixation test)
Treatment: No specific treatment
Geographic distribution: There has never been an outbreak in the UK. Endemic countries include; sub-Saharan Africa. Outbreaks reported in Spain, Portugal and Morocco last reported between 1987-1990.
Prevention:
In endemic countries; vaccination and management measures. There is a detailed prevention and control plan for Great Britain laid out in the 'African horse sickness control strategy for Great Britain' (https://www.gov.uk/government/publications/african-horse-sickness-control-strategy)
Notifiable in the UK: confirmed cases must be reported to Defra The mixed form appears to be the most common and cases have a combination of pathologies detected post-mortem, although this is often not clinically apparent. Mixed cases present with pyrexia and milder/subclinical pulmonary or cardiac signs, which are followed by oedema, cardiac failure and respiratory failure. Horsesickness fever is associated with a mild fever that may be subclinical and is seen only in reservoir species and partially immune horses. African horse sickness is almost exclusively a disease of equids and is not considered zoonotic, although disease associated with the virus has been described in humans following nasal exposure to virus from broken vaccine vials [2] . No specific treatment is available for AHS and vaccination and management measures are used to control the disease in endemic areas [1; 3] .
Epidemiology of the virus and vectors
The geographical distribution and seasonal occurrence of AHS are linked to vector epidemiology. The disease is endemic in parts of sub-Saharan Africa, with epizootics reported in northern Africa, southern Europe and western Asia. The furthest north that an outbreak of AHS has been recorded is the western Mediterranean region (Spain, Portugal and Morocco), with the last outbreak here occurring between 1987-1990 [4] . There have been no further outbreaks in Europe. Historically, the risk of AHS to the UK was considered to be very low due to the lack of suitable species of midge vector.
However, recent changes in the global distribution of several vector-borne viral diseases have led to concerns that AHS will increasingly threaten parts of the world currently considered disease-free. Bluetongue virus of ruminants is of particular interest, as it is closely related to AHS virus and shares the same vectors in areas where both viruses are endemic. Before the year 2006, bluetongue had never occurred in northern Europe. This was believed to be because no competent vector species of midges were present this far north. However, there is substantial evidence that European species of midges present in the area acted as Bluetongue virus vectors after 2006 [5; 6] . This may be because of climate change associated alterations in the abilities of the midge species to act as vectors. These species are therefore considered potential vectors of AHS virus in northern Europe and have been found on equine properties in the southeast UK [7] . It is therefore considered possible that an outbreak of AHS could occur in the UK, if the virus were able to reach the area (either within an equid or vector).
The OIE regulations for disease-free countries are extensive, making the risk of AHS entry via a legally transported horse very low. Indeed, AHS is listed amongst six diseases for which the OIE requires additional mitigation measures in High Health High Performance horses. It is essential that international equid transport remains closely monitored and illegal movement is prevented. Veterinary surgeons attending cases with clinical findings consistent with AHS, in particular in any equids that have travelled or are housed with equids that have travelled, must remain vigilant to the possibility of the disease occurring in areas currently considered disease-free.
Significance of an outbreak to the UK
Due to the combination of high mortality and the ability of the virus to expand out of its endemic area without warning, the World Organisation for Animal Health (OIE) classifies AHS as a listed disease. Official AHS disease-free status can be obtained from the OIE on fulfilment of a number of requirements and the organisation provides up-todate detail on global disease status [8] . Given the severe mortality rates seen in naïve populations, a UK outbreak of AHS would have devastating effects on animal welfare and major economic consequences for the equine industry [9] . It has been estimated that a widespread outbreak of AHS in the UK that continued for 1-2 years would wipe out around 50% of the economic impact of the equine industry to the country (currently around £7billion) [10] . 
MAINTENANCE OF OIE DISEASE-FREE STATUS VACCINATION ENDS AND RESTRICTIONS GRADUALLY LIFTED
Current plans in the event of an outbreak and summary of important areas of research As African horse sickness is notifiable in OIE disease-free countries, suspicion must be reported immediately to the relevant authorities. If the virus is confirmed as being present, the immediate priority is to stop it from spreading into the (potential) vector population. The detailed prevention and control plan for Great Britain is laid out in the 'African horse sickness control strategy for Great Britain', which is freely available online [11] . A summary of the measures is shown in figure  3 .
The following points are of particular interest to veterinary surgeons:  Culling of horses -In Great Britain, culling of horses that are infected or suspected to be infected would occur until it became clear that the virus was circulating extensively within the vector population (at which point culling would no longer be effective). Exclusions from culling would be available for animals of genetic importance if they could be immediately moved to fully operational vector -proofed facilities. Unfortunately, very few such facilities exist and the rapid mortality and disease severity seen in naïve horses makes their use mostly hypothetical. Public outcry and complex legal situations would no doubt quickly arise.

Tracking of horses -Detailed information on the numbers, movements and whereabouts of horses is not currently available throughout the UK. This is essential data when modelling disease outbreaks and would pose a significant barrier to effective outbreak control. A new central equine database is being introduced within the European Union, however the implications of this for the UK are unclear.
 Prevention of vector-host interaction -As we all know from insect bite hypersensitivity, there is no truly effective way to prevent midges biting horses. Stabling of horses and the use of insect blankets with both neck cover and hood would be of some benefit [12; 13] . The use of repellents and insecticides are another possible method to control the spread of vector-borne disease, however there is little evidence to recommend any particular product.
Vaccination -In the event of an AHS outbreak this is the most effective way of bringing the disease under control and vaccination was used successfully in Spain during 1987-1991. [4] . This is a key part of the control strategy and vaccination would almost certainly be used in the UK.
Annual vaccination with live-attenuated strains is the mainstay of controlling AHS in South Africa. Unfortunately reversion to virulence of attenuated vaccine strains has been demonstrated, raising serious concerns over their use [14] . Consequently there has been a significant drive to promote stakeholder investment in the development of alternative vaccine types. In particular, a new AHS vaccine which would allow differentiation of infected from vaccinated animals based on serological or PCR testing (DIVA technology) would be hugely useful for both outbreak control and to assist the international travel of horses from sub-Saharan Africa. This is considered a key requirement at this time, particularly as previously mentioned EU vaccine banks have not materialized.
POST MORTEM EXAMINATIONS report for the second quarter 2019
Details about post-mortem examinations were reported by two UK Veterinary Schools and four other contributing laboratories. Data from each laboratory is organised by the laboratories regional location. There may be more than one laboratory reporting information for each region.
East and South East of England
A total of 38 cases were examined by post mortem 11 aborted fetuses and fetal membranes were examined.
Summary of post-mortem findings for aborted fetuses for the second quarter 2019: *PCR and histopathology was performed to screen for Equine Herpes Virus-1/-4 infection in all cases. Where abortion/still born cases had no final diagnosis reached, hypotheses were made for each case with the intention for interpretation by the submitting veterinarian, relating fetus and fetal membranes post mortem findings to concurrent clinical history to affirm the most likely conclusion. For every abortion/still birth case, congenital and common infectious causes had been ruled out.
Seven cases of neonatal death (within first week of age) were examined.

There were three cases of intrapartum still birth and one of the three was found to have meconium aspiration.
Three cases of dystocia were examined. One was confirmed to have Warmblood Fragile Foal Syndrome (cutaneous defects, scoliosis and limb deformities), confirmed by genotyping. The other two cases had signs of perinatal hypoxia/organ dysfunction as a result of dystocia.
One case had mild lesions in the brain sections examined which were insufficient to explain the severity of the clinical signs. However, despite the areas of pulmonary atelectasis, oedema and congestion, there were no malacic or hypoxia-induced changes of the grey matter that would be consistent with "neonatal maladjustment syndrome". The only lesions present in the sections examined could be suggestive of a mild encephalitis but no conclusive diagnosis was made.
Post Mortem Diagnosis
Total Comments Congenital abnormalities 1 Cranium had cranioschysis and hydranencephaly with left lateral septum deviation and brachygnatia. The body was found to have torticollis and arthrogryposis.
Placentitis
3
One case had focal mild acute neutrophilic placentitis (chorioallantois);
Enterobacter aerogenes and E.coli isolated.
One case had a heavy growth of E. coli in the placenta and fetal lungs which was potentially associated with chronic placentitis and the cause of the fetal lesions observed.
One case had a severe multifocal acute necrosuppurative placentitis with necrosis, dystrophic mineralization and intralesional bacteria. Results suggested a bacterial placentitis caused by Streptococcus zooepidemicus with possible spread to fetal tissues (lung).
Placental insufficiency
2 The nature of the placental lesions in one case could indicate that placental insufficiency was ultimately the cause of the abortion. The placenta had moderate subacute multifocal mineralization and osseous metaplasia with marked acute haemorrhage. The fetal organs examined showed congestive changes in the lung and lymph nodes.
Another case had changes present that were compatible with placental insufficiency, likely secondary to both partial body implantation and thickening of the pregnant horn and portions of the body.
Placental mineralization 1
Due to severe autolytic changes in all tissues, it was not possible to determine the exact cause of abortion. However, there was mineralization of blood vessel walls in the placental stroma and this is a change that can seldom be observed with ischemic events.
Umbilical Cord Torsion 2 No further information
No final diagnosis* 2 Late-term abortion: Non-diagnostic (autolysed and no placental tissue).
Lesions in the liver and kidney indicated severe hypoxia of uncertain cause.
Two cardiovascular cases were examined. One case was found to have intracardiac melanomas and presented with sudden death. One case was found to have a ventricular septal defect, over-riding aorta with aortic regurgitation, mild pulmonary regurgitation and hypertrophy of the right ventricle.
Two gastrointestinal cases were examined. In one, the lesions observed included intestinal impaction due to hypomotility with subsequent reflux and acute aspiration of gastric contents, consistent with a clinical diagnosis of equine dysautonomia (grass sickness). Histology also confirmed the diagnosis. In a second case, lesions found were consistent with a severe acute typhlocolitis of bacterial origin. Given the age of the animal (yearling) and the large numbers of Gram positive bacterial colonies observed within the intestinal tissues, the main differential aetiology was Clostridium and C. perfringens was confirmed by PCR on caecal contents.
Two hepatic cases were examined. One was found to have severe acute to subacute hepatic necrosis with vacuolar degeneration, moderate biliary hyperplasia and hepatic encephalopathy and this case tested negative for equine parvovirus and hepacivirus. One case was diagnosed with severe idiopathic juvenile hepatic fibrosis, with nodular regeneration and bile stasis.
Six musculoskeletal cases were examined. One neurological case was examined and diagnosed with a traumatic basilar skull fracture, with optic nerve compression.
Four respiratory cases were examined.

One had a tracheal perforation, pneumomediastinum, pneumothorax and marked subcutaneous emphysema.
One case had an acute bronchopneumonia (Streptococcus zooepidemicus isolated) and severe large intestinal tympany (suspected secondary to dysbiosis).
In one case, collectively all lesions indicated that the cause of death was associated to respiratory and bacterial septicaemia associated with bronchoaspiration. The bacteriology lab isolated Burkholderia cepacea which has previously been isolated in other cases of equine aspiration pneumonias. There was also evidence of renal tubular necrosis, likely associated with sepsis and severe hypoxia.
One case had haemothorax and haemorrhage in the pelvic canal of unconfirmed cause and severe acute diaphragmatic rupture. There was no evidence of rupture of any of the major vessels, no apparent signs of trauma and no major microscopic abnormalities in the bone marrow.
One splenic case was examined and diagnosis of acute splenic rupture (traumatic) with haemabdomen made.
Two welfare cases were examined. One was found to have chronic hepatic disease consistent with ragwort toxicity and phthisis bulb secondary to a corneal perforation. Another case was found to have severe chronic laminitis with pedal bone detachment and rotation, sole abrasion and focal sole abscess formation (hindlimbs).
Scotland
A total of five cases were examined Two gastrointestinal cases were examined. One had idiopathic muscular hypertrophy. The second case had an intestinal diverticulae/pseudodiverticulae
One musculoskeletal case was examined and was found to have a fracture of the olecranon.
Two neoplastic cases were examined. One had a haemangiosarcoma and the other had enteric lymphoma.
South West England
A total of 18 cases were examined
One neonatal case was examined and a diagnosis of rupture of the urinary bladder was made, likely facilitated by a pre-existing congenital bladder wall epithelialization defect.
Nine gastrointestinal cases were examined.

One case of gastric rupture was examined.
A case of subacute equine grass sickness was examined and found to have multifocal oesophageal ulcers, segmental reddening to the small intestine and stagnated faecal material in the colon, accompanied by serosal fibrinous strands. Histopathology confirmed the diagnosis, with a mixed, predominantly lymphoplasmacytic inflammation evident in the ileum and the myenteric and submucosal plexi had marked and diffuse hypoganglionosis.
One case of moderate to severe, diffuse enterotiflocolitis was examined, with diffusely reddened intestinal mucosa.
A case was found to have a moderate to severe, diffuse enteritis affecting the length of the small intestine and moderate colitis, becoming fibrinonecrotic in the distal colon and rectum.
Several pedunculated lipomas were observed on the intestinal serosa and on the mesentery of one case.
Diffuse colonic oedema with multifocal petechiae, evident on the serosa and mucosa of the colon and on the mesentery was found in one case  A diagnosis of right dorsal displacement of the large colon with a <180° volvulus was made in one case, with the pelvic flexure located close to the sternum. The left dorsal colon had multifocal petechial and ecchymotic mucosal haemorrhages and multiple tortuous vessels were evident in the mesentery of the small intestine.
One case was found to have numerous fibrous tags on the serosal surface of the large colon, the peritoneal surface of the abdominal wall and the diaphragm.
A case was diagnosed with severe segmental, fibrinonecrotizing colitis resulting in colonic rupture and subsequent peritonitis: the abdominal cavity was filled with large amounts of cloudy reddishbrown fluid, in which large quantities of fibrous intestinal contents floated freely.
One other case was examined and the right labial vein was found to contain a 3x0.5cm thrombus. There were multiple subcutaneous haemorrhages in the head region and in the right masseter muscle. In the cranial neck, caudal and medial to the right thyroid, the connective tissues contained an approximately 3.5x2x 1 cm, soft, encapsulated mass comprising a fatty, yellow-tan, capsule surrounding gelatinous, olive green-yellow, spreadable material, accompanied by multiple dark red-black foci in the oesophageal adventitia and adjacent connective tissues.
One respiratory case was examined and found to have a severe suppurative bronchopneumonia with abscessation of the left lung, mainly involving the cranial lobe and the cranial half of the caudal lobe. There were multiple caverns ranging approximately from 1 to 7 cm diameter, filled with floccular pus. Multiple areas of subpleural interstitial thickening were observed, accompanied by haemorrhagic halo surrounding the lung lesions and yellowish fibrin stratified on the lung pleural surface. The tracheobronchial lymph nodes were moderately enlarged and oedematous. Pus was present free in the trachea and in the major bronchi.
Two hepatic cases were examined. One was found to have multiple white spots within the parenchyma. The other case was found to have two hydatid cysts, each measuring 3cm in diameter. Both were incidental post-mortem findings and the cause of death was no reported.
One musculoskeletal case was examined and diagnosed with white line disease.
One neoplastic cases was examined and diagnosed with multiple nodular, ulcerative, focally infiltrative penile sheath masses consistent with malignant sarcoids.
Two urogenital cases were examined. One was found to have mildly dilated renal pelvices. A diagnosis of mild hydronephrosis due to external compression of the urethra by a large mass was made and the mass was confirmed to be a sarcoid. The second case was diagnosed with a patent urachus.
Northern Ireland
A total of four cases were examined
One case of neonatal death was examined. There was meconium staining at the anus and the carcass appeared hyperaemic and mildly oedematous. Septacaemia was suspected and E. coli was cultured.
One gastrointestinal case was examined and was found to have a caecal and colonic displacement (right dorsal displacement). The right dorsal and ventral colon were displaced lateral to the base of the caecum and the colonic wall was friable at the sternal flexure, which was displaced to the right caudal abdomen adjacent to the base of the caecum. The caecum was displaced medially and extended across the abdomen.
One hepatic case was examined. The liver was autolytic and fragmenting on handling. There were no normal hepatocytes remaining, of those that were present only the cell outline remained and the cytoplasm was replaced by large vacuoles.
One case of sudden death was examined. There were no significant abnormalities detected on gross post mortem but autolysis made interpretation of findings difficult. Samples were too autolytic for meaningful histopathology and toxicology and botulism testing was negative.
